Should dual antiplatelet therapy after drug-eluting stents be continued for more than 1 year? Dual Antiplatelet Therapy After Drug-Eluting Stents Should Be Continued for More Than One Year and Preferably Indefinitely

被引：10

作者：

Chhatriwalla, Adnan K. ^{[1
]}

Bhatt, Deepak L. ^{[2
]}

机构：

[1] Cleveland Clin, Div Cardiovasc Med, Cleveland, OH 44106 USA

[2] VA Boston Hlth Care Syst, Div Cardiol, Boston, MA USA

来源：

CIRCULATION-CARDIOVASCULAR INTERVENTIONS | 2008年 / 1卷 / 03期

关键词：

D O I：

10.1161/CIRCINTERVENTIONS.108.811380

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

[No abstract available]

引用

页码：217 / 225

页数：9

共 63 条

[1] Incidence and predictors of drug-eluting stent thrombosis during and after discontinuation of thienopyridine treatment [J].

Airoldi, Flavio ;

Colombo, Antonio ;

Morici, Nuccia ;

Latib, Azeem ;

Cosgrave, John ;

Buellesfeld, Lutz ;

Bonizzoni, Erminio ;

Carlino, Mauro ;

Gerckens, Ulrich ;

Godino, Cosmo ;

Melzi, Gloria ;

Michev, Iassen ;

Montorfano, Matteo ;

Sangiorgi, Giuseppe Massimo ;

Qasim, Asif ;

Chieffo, Alaide ;

Briguori, Carlo ;

Grube, Eberhard .

CIRCULATION, 2007, 116 (07) :745-754

[2] A randomized study assessing the impact of cilostazol on platelet function profiles in patients with diabetes mellitus and coronary artery disease on dual antiplatelet therapy: results of the OPTIMUS-2 study [J].

Angiolillo, Dominick J. ;

Capranzano, Piera ;

Goto, Shinya ;

Aslam, Mohammed ;

Desai, Bhaloo ;

Charlton, Ronald K. ;

Suzuki, Yoshie ;

Box, Lyndon C. ;

Shoemaker, Steven B. ;

Zenni, Martin M. ;

Guzman, Luis A. ;

Bass, Theodore A. .

EUROPEAN HEART JOURNAL, 2008, 29 (18) :2202-2211

[3] Risk of thrombosis with the use of sirolimus-eluting stents for percutaneous coronary intervention (from registry and clinical trial data) [J].

Bavry, AA ;

Kumbhani, DJ ;

Helton, TJ ;

Bhatt, DL .

AMERICAN JOURNAL OF CARDIOLOGY, 2005, 95 (12) :1469-1472

[4] What is the risk of stent thrombosis associated with the use of paclitaxel-eluting stents for percutaneous coronary intervention? A meta-analysis [J].

Bavry, AA ;

Kumbhani, DJ ;

Helton, TJ ;

Bhatt, DL .

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2005, 45 (06) :941-946

[5] Appropriate use of drug-eluting stents: balancing the reduction in restenosis with the concern of bate thrombosis [J].

Bavry, Anthony A. ;

Bhatt, Deepak L. .

LANCET, 2008, 371 (9630) :2134-2143

[6] Drug-eluting stents - Dual antiplatelet therapy for every survivor? [J].

Bavry, Anthony A. ;

Bhatt, Deepak L. .

CIRCULATION, 2007, 116 (07) :696-699

[7] Late thrombosis of drug-eluting stents: A meta-analysis of randomized clinical trials [J].

Bavry, Anthony A. ;

Kumbhani, Dharam J. ;

Helton, Thomas J. ;

Borek, Przemyslaw P. ;

Mood, Girish R. ;

Bhatt, Deepak L. .

AMERICAN JOURNAL OF MEDICINE, 2006, 119 (12) :1056-1061

[8] Double-blind study of the safety of clopidogrel with and without a loading dose in combination with aspirin compared with ticlopidine in combination with aspirin after coronary stenting - The Clopidogrel Aspirin Stent International Cooperative Study (CLASSICS) [J].

Bertrand, ME ;

Rupprecht, HJ ;

Urban, P ;

Gershlick, AH .

CIRCULATION, 2000, 102 (06) :624-629

[9] Intensifying platelet inhibition - Navigating between scylla and charybdis [J].

Bhatt, Deepak L. .

NEW ENGLAND JOURNAL OF MEDICINE, 2007, 357 (20) :2078-2081

[10] Patients with prior myocardial infarction, stroke, or symptomatic peripheral arterial disease in the CHARISMA trial [J].

Bhatt, Deepak L. ;

Flather, Marcus D. ;

Hacke, Werner ;

Berger, Peter B. ;

Black, Henry R. ;

Boden, William E. ;

Cacoub, Patrice ;

Cohen, Eric A. ;

Creager, Mark A. ;

Easton, J. Donald ;

Hamm, Christian W. ;

Hankey, Graeme J. ;

Johnston, S. Claiborne ;

Mak, Koon-Hou ;

Mas, Jean-Louis ;

Montalescot, Gilles ;

Pearson, Thomas A. ;

Steg, P. Gabriel ;

Steinhubl, Steven R. ;

Weber, Michael A. ;

Fabry-Ribaudo, Liz ;

Hu, Tingfei ;

Topol, Eric J. ;

Fox, A. A. .

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2007, 49 (19) :1982-1988

← 1 2 3 4 5 6 7 →